SCHEMBL15322299

SCHEMBL15322299

Cc1cc(Br)c([N+](=O)[O-])c2nccnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TDP1 Q9NUW8 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ GRIN2D O15399 1/20 0.36
▸ GRIN3B O60391 1/20 0.36
▸ GRIN1 Q05586 1/20 0.36
▸ GRIN2A Q12879 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ GRIN2C Q14957 1/20 0.36
▸ GRIN3A Q8TCU5 1/20 0.36
▸ NPY1R P25929 3/20 0.35
▸ TSHR P16473 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPT P10636 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15323178 0.77 MEN1 (0.49) KMT2AMEN1SMN1; SMN2TDP1ALDH1A1
SCHEMBL27711986 0.72 CYP1A2 (0.46) KMT2AMEN1TDP1ALDH1A1CYP1A2
SCHEMBL31182415 0.71 MEN1 (0.46) KMT2AMEN1SMN1; SMN2TDP1ALDH1A1
SCHEMBL31500715 0.71 GPR35 (0.34) KMT2AMEN1TDP1ALDH1A1CYP1A2
SCHEMBL25637697 0.70 MEN1 (0.63) KMT2AMEN1TDP1ALDH1A1CYP1A2
SCHEMBL29363774 0.68 GRIN2D (0.51) KMT2AMEN1SMN1; SMN2TDP1ALDH1A1
SCHEMBL28977893 0.68 GRIN2D (0.47) KMT2AMEN1SMN1; SMN2TDP1ALDH1A1
SCHEMBL22805139 0.68 GRIN2D (0.51) KMT2AMEN1SMN1; SMN2TDP1ALDH1A1
SCHEMBL3502541 0.68 MEN1 (0.50) KMT2AMEN1SMN1; SMN2ALDH1A1MAPT
SCHEMBL5708856 0.68 ALDH1A1 (0.36) KMT2AMEN1TDP1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 — — WO disclosed
WO-2013153535-A1 TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2013-10-17 — — WO disclosed
Send feedback